Lee, Jong Min
Kim, Youlim
Choi, Joon Young
Ra, Seung Won
Kim, Deog Kyeom
Kim, Tae-Hyung
Yoon, Hyung Kyu
Yoo, Kwang Ha
Jung, Ki-Suck
Rhee, Chin Kook
Article History
Received: 5 June 2024
Accepted: 15 May 2025
First Online: 23 May 2025
Declarations
:
: This study protocol was approved by the Institutional Review Board of KONKUK university medical center and all participants in the cohorts provided written informed consent (IRB No. KHH1010338). All hospitals involved in the KOCOSS cohort obtained approval from the Institutional Review Board Committee and informed consent from their patients.
: No applicable.
: CK Rhee received consulting/lecture fees from MSD, AstraZeneca, GSK, Novartis, Takeda, Mundipharma, Boehringer-Ingelheim, Teva, Sanofi, and Bayer.